跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 83,164 条关于
“STK11-mutated cancers”
全部
83,164
临床试验
71,608
药物
1,549
机构
286
资讯
9,721
去年
BerGenBio's AXL Inhibitor Receives FDA Fast Track for STK11-Mutated Cancers Amidst Leadership Transition
去年
NGS-Guided Treatment Strategy Shows Promise for STK11/KEAP1-Mutated NSCLC Patients
去年
BerGenBio's AXL Inhibitor Shows Promise in STK11-Mutated Lung Cancer, Faces Leadership Transition
2年前
Inavolisib Shows Promise in PIK3CA-Mutated Advanced Solid Tumors
去年
Panbela Therapeutics Initiates Phase I Trial of CPP-1X-S in STK11 Mutant NSCLC
2年前
Glecirasib Shows Promise in Pancreatic Cancer and Other Solid Tumors at ASCO GI 2024
去年
Immunotherapy Strategies Evolving for NSCLC with KRAS and STK11 Mutations
2个月前
PARP Inhibitors Expand Beyond BRCA-Mutated Cancers: Emerging Evidence Across Solid Tumors and Combination Strategies
去年
UCLA Researchers Receive $950,000 Grant to Launch Multi-Institutional Trial of Zipalertinib for EGFR-Mutated Cancers
2年前
Prelude Therapeutics' PRT3789 Shows Promise in SMARCA4-Mutated Cancers
第 1 页,共 973 页
上一页
下一页